{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:30:24Z","timestamp":1794378624352,"version":"4.9.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1007\/s40744-019-0159-1","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T19:42:52Z","timestamp":1558122172000},"page":"305-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Psoriatic Arthritis: What is Happening at the Joint?"],"prefix":"10.1007","volume":"6","author":[{"given":"Jennifer","family":"Belasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"159_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957\u201370.","journal-title":"N Engl J Med"},{"key":"159_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","volume":"17","author":"LC Coates","year":"2017","unstructured":"Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med (Lond). 2017;17:65\u201370.","journal-title":"Clin Med (Lond)"},{"key":"159_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.rdc.2015.07.003","volume":"41","author":"DD Gladman","year":"2015","unstructured":"Gladman DD. Clinical features and diagnostic considerations in psoriatic arthritis. Rheum Dis Clin N Am. 2015;41:569\u201379.","journal-title":"Rheum Dis Clin N Am"},{"key":"159_CR4","first-page":"S26","volume":"33","author":"ML Acosta Felquer","year":"2015","unstructured":"Acosta Felquer ML, FitzGerald O. Peripheral joint involvement in psoriatic arthritis patients. Clin Exp Rheumatol. 2015;33:S26\u201330.","journal-title":"Clin Exp Rheumatol"},{"key":"159_CR5","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3899\/jrheum.141545","volume":"42","author":"A Haddad","year":"2015","unstructured":"Haddad A, Johnson SR, Somaily M, et al. Psoriatic arthritis mutilans: clinical and radiographic criteria. A systematic review. J Rheumatol. 2015;42:1432\u20138.","journal-title":"J Rheumatol"},{"key":"159_CR6","first-page":"459","volume":"34","author":"A Zabotti","year":"2016","unstructured":"Zabotti A, Salvin S, Quartuccio L, De Vita S. Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands. Clin Exp Rheumatol. 2016;34:459\u201365.","journal-title":"Clin Exp Rheumatol"},{"key":"159_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/annrheumdis-2017-212328","volume":"77","author":"R Charlton","year":"2018","unstructured":"Charlton R, Green A, Shaddick G, et al. Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study. Ann Rheum Dis. 2018;77:277\u201380.","journal-title":"Ann Rheum Dis."},{"key":"159_CR8","first-page":"S20","volume":"33","author":"M Mortezavi","year":"2015","unstructured":"Mortezavi M, Thiele R, Ritchlin C. The joint in psoriatic arthritis. Clin Exp Rheumatol. 2015;33:S20\u2013S2525.","journal-title":"Clin Exp Rheumatol"},{"key":"159_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74:1045\u201350.","journal-title":"Ann Rheum Dis"},{"key":"159_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","volume":"74","author":"PJ Mease","year":"2014","unstructured":"Mease PJ, Armstrong AW. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs. 2014;74:423\u201341.","journal-title":"Drugs"},{"key":"159_CR11","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/art.38995","volume":"67","author":"J Belasco","year":"2015","unstructured":"Belasco J, Louie JS, Gulati N, et al. Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis. Arthritis Rheumatol. 2015;67:934\u201344.","journal-title":"Arthritis Rheumatol"},{"key":"159_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00296-015-3387-x","volume":"36","author":"M Rossini","year":"2016","unstructured":"Rossini M, Viapiana O, Adami S, Idolazzi L, Fracassi E, Gatti D. Focal bone involvement in inflammatory arthritis: the role of IL17. Rheumatol Int. 2016;36:469\u201382.","journal-title":"Rheumatol Int"},{"key":"159_CR13","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1128\/MCB.26.8.2955-2964.2006","volume":"26","author":"W Si","year":"2006","unstructured":"Si W, Kang Q, Luu HH, et al. CCN1\/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol. 2006;26:2955\u201364.","journal-title":"Mol Cell Biol"},{"key":"159_CR14","doi-asserted-by":"publisher","first-page":"a021899","DOI":"10.1101\/cshperspect.a021899","volume":"8","author":"T Katagiri","year":"2016","unstructured":"Katagiri T, Watabe T. Bone morphogenetic proteins. Cold Spring Harb Perspect Biol. 2016;8:a021899.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"159_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1124\/mol.62.1.58","volume":"62","author":"NJ Laping","year":"2002","unstructured":"Laping NJ, Grygielko E, Mathur A, et al. Inhibition of transforming growth factor (TGF)-\u03b21-induced extracellular matrix with a novel inhibitor of the TGF-\u03b2 type I receptor kinase activity: SB-431542. Mol Pharmacol. 2002;62:58\u201364.","journal-title":"Mol Pharmacol"},{"key":"159_CR16","doi-asserted-by":"publisher","first-page":"630620","DOI":"10.1155\/2013\/630620","volume":"2013","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto T. Angiogenic and inflammatory properties of psoriatic arthritis. ISRN Dermatol. 2013;2013:630620.","journal-title":"ISRN Dermatol"},{"key":"159_CR17","doi-asserted-by":"publisher","first-page":"e000025","DOI":"10.1136\/rmdopen-2014-000025","volume":"1","author":"DJ Veale","year":"2015","unstructured":"Veale DJ, Fearon U. What makes psoriatic and rheumatoid arthritis so different? RMD Open. 2015;1:e000025.","journal-title":"RMD Open"},{"key":"159_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s11926-006-0062-y","volume":"8","author":"PJ Healy","year":"2006","unstructured":"Healy PJ, Helliwell PS. Dactylitis: pathogenesis and clinical considerations. Curr Rheumatol Rep. 2006;8:338\u201341.","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl 1","key":"159_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1468-3083.2009.03363.x","volume":"23","author":"D McGonagle","year":"2009","unstructured":"McGonagle D. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol. 2009;23(Suppl 1):9\u201313.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"159_CR20","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/acr.23174","volume":"69","author":"A Polachek","year":"2017","unstructured":"Polachek A, Li S, Chandran V, Gladman DD. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: incidence, prevalence, characteristics, and outcome. Arthritis Care Res (Hoboken). 2017;69:1685\u201391.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"159_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/art.39458","volume":"68","author":"AS Kehl","year":"2016","unstructured":"Kehl AS, Corr M, Weisman MH. Enthesitis: new insights into pathogenesis, diagnostic modalities, and treatment. Arthritis Rheumatol. 2016;68:312\u201322.","journal-title":"Arthritis Rheumatol"},{"key":"159_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.berh.2014.10.009","volume":"28","author":"P Jacques","year":"2014","unstructured":"Jacques P, McGonagle D. The role of mechanical stress in the pathogenesis of spondyloarthritis and how to combat it. Best Pract Res Clin Rheumatol. 2014;28:703\u201310.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"159_CR23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/bjd.13272","volume":"171","author":"A Langenbruch","year":"2014","unstructured":"Langenbruch A, Radtke MA, Krensel M, Jacobi A, Reich K, Augustin M. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. Br J Dermatol. 2014;171:1123\u20138.","journal-title":"Br J Dermatol"},{"key":"159_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5114\/reum.2017.68912","volume":"55","author":"P Sobolewski","year":"2017","unstructured":"Sobolewski P, Walecka I, Dopytalska K. Nail involvement in psoriatic arthritis. Reumatologia. 2017;55:131\u20135.","journal-title":"Reumatologia"},{"key":"159_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3899\/jrheum.110893","volume":"39","author":"A Marchesoni","year":"2012","unstructured":"Marchesoni A, Atzeni F, Spadaro A, et al. Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol. 2012;39:849\u201355.","journal-title":"J Rheumatol"},{"key":"159_CR26","doi-asserted-by":"publisher","first-page":"e000053","DOI":"10.1136\/rmdopen-2015-000053","volume":"1","author":"X Baraliakos","year":"2015","unstructured":"Baraliakos X, Braun J. Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences? RMD Open. 2015;1:e000053.","journal-title":"RMD Open"},{"key":"159_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000341536","volume":"225","author":"DG McGonagle","year":"2012","unstructured":"McGonagle DG, Helliwell P, Veale D. Enthesitis in psoriatic disease. Dermatology. 2012;225:100\u20139.","journal-title":"Dermatology"},{"key":"159_CR28","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/acr.21733","volume":"64","author":"JE Freeston","year":"2012","unstructured":"Freeston JE, Coates LC, Helliwell PS, et al. Is there subclinical enthesitis in early psoriatic arthritis? A clinical comparison with power Doppler ultrasound. Arthritis Care Res (Hoboken). 2012;64:1617\u201321.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"159_CR29","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/annrheumdis-2013-204239","volume":"74","author":"RP Poggenborg","year":"2015","unstructured":"Poggenborg RP, Eshed I, \u00d8stergaard M, et al. Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by 'head-to-toe' whole-body MRI and clinical examination. Ann Rheum Dis. 2015;74:823\u20139.","journal-title":"Ann Rheum Dis"},{"key":"159_CR30","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665\u2013733.","journal-title":"Arthritis Rheum"},{"key":"159_CR31","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/jbmr.2109","volume":"29","author":"R Kocijan","year":"2014","unstructured":"Kocijan R, Finzel S, Englbrecht M, Engelke K, Rech J, Schett G. Decreased quantity and quality of the periarticular and nonperiarticular bone in patients with rheumatoid arthritis: a cross-sectional HR-pQCT study. J Bone Miner Res. 2014;29:1005\u2013144.","journal-title":"J Bone Miner Res"},{"key":"159_CR32","doi-asserted-by":"publisher","first-page":"ii56","DOI":"10.1093\/rheumatology\/kew345","volume":"55","author":"SR Goldring","year":"2016","unstructured":"Goldring SR. Differential mechanisms of de-regulated bone formation in rheumatoid arthritis and spondyloarthritis. Rheumatology (Oxford). 2016;55:ii56\u2013ii60.","journal-title":"Rheumatology (Oxford)"},{"key":"159_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1055\/s-0032-1329893","volume":"16","author":"M \u00d8stergaard","year":"2012","unstructured":"\u00d8stergaard M. Can imaging be used for inflammatory arthritis screening? Semin Musculoskelet Radiol. 2012;16:401\u20139.","journal-title":"Semin Musculoskelet Radiol"},{"key":"159_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejim.2013.08.700","volume":"25","author":"O Epis","year":"2014","unstructured":"Epis O, Paoletti F, d'Errico T, et al. Ultrasonography in the diagnosis and management of patients with inflammatory arthritides. Eur J Intern Med. 2014;25:103\u201311.","journal-title":"Eur J Intern Med"},{"key":"159_CR35","first-page":"2485","volume":"32","author":"RJ Wakefield","year":"2005","unstructured":"Wakefield RJ, Balint PV, Szkudlarek M, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32:2485\u20137.","journal-title":"J Rheumatol"},{"key":"159_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1759720X10394031","volume":"3","author":"RP Poggenborg","year":"2011","unstructured":"Poggenborg RP, Terslev L, Pedersen SJ, \u00d8stergaard M. Recent advances in imaging in psoriatic arthritis. Ther Adv Musculoskelet Dis. 2011;3:43\u201353.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"159_CR37","first-page":"1217","volume":"34","author":"I Olivieri","year":"2007","unstructured":"Olivieri I, Padula A, Scarano E, Scarpa R. Dactylitis or \"sausage-shaped\" digit. J Rheumatol. 2007;34:1217\u201322.","journal-title":"J Rheumatol"},{"key":"159_CR38","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1002\/art.27571","volume":"62","author":"U Weber","year":"2010","unstructured":"Weber U, Lambert RG, \u00d8stergaard M, Hodler J, Pedersen SJ, Maksymowych WP. The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum. 2010;62:3048\u201358.","journal-title":"Arthritis Rheum"},{"key":"159_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13317-013-0057-4","volume":"5","author":"B Marinoni","year":"2014","unstructured":"Marinoni B, Ceribelli A, Massarotti MS, Selmi C. The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications. Auto Immun Highlights. 2014;5:9\u201319.","journal-title":"Auto Immun Highlights"},{"key":"159_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000471798","volume":"233","author":"J Li","year":"2017","unstructured":"Li J, Liu L, Rui W, et al. New interleukins in psoriasis and psoriatic arthritis patients: the possible roles of interleukin-33 to interleukin-38 in disease activities and bone erosions. Dermatology. 2017;233:37\u201346.","journal-title":"Dermatology"},{"key":"159_CR41","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3390\/ijms17081255","volume":"17","author":"H Przepiera-B\u0119dzak","year":"2016","unstructured":"Przepiera-B\u0119dzak H, Fischer K, Brzosko M. Serum interleukin-18, fetuin-A, soluble intercellular adhesion molecule-1, and endothelin-1 in ankylosing spondylitis, psoriatic arthritis, and SAPHO syndrome. Int J Mol Sci. 2016;17:1255. https:\/\/doi.org\/10.3390\/ijms17081255.","journal-title":"Int J Mol Sci"},{"key":"159_CR42","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/ard.2003.016428","volume":"63","author":"T Rooney","year":"2004","unstructured":"Rooney T, Murphy E, Benito M, et al. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis. Ann Rheum Dis. 2004;63:1393\u20138.","journal-title":"Ann Rheum Dis"},{"key":"159_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","volume":"73","author":"P Jacques","year":"2014","unstructured":"Jacques P, Lambrecht S, Verheugen E, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2014;73:437\u201345.","journal-title":"Ann Rheum Dis"},{"key":"159_CR44","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, et al. IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4\u2212CD8\u2212 entheseal resident T cells. Nat Med. 2012;18:1069\u201376.","journal-title":"Nat Med"},{"key":"159_CR45","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.39732","volume":"68","author":"A Reinhardt","year":"2016","unstructured":"Reinhardt A, Yevsa T, Worbs T, et al. Interleukin-23-dependent \u03b3\/\u03b4 T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice. Arthritis Rheumatol. 2016;68:2476\u201386.","journal-title":"Arthritis Rheumatol"},{"key":"159_CR46","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s10067-014-2603-5","volume":"33","author":"L Costa","year":"2014","unstructured":"Costa L, Caso F, Cantarini L, Del Puente A, Scarpa R, Atteno M. Efficacy of tocilizumab in a patient with refractory psoriatic arthritis. Clin Rheumatol. 2014;33:1355\u20137.","journal-title":"Clin Rheumatol"},{"key":"159_CR47","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/rheumatology\/kes432","volume":"52","author":"M Hughes","year":"2013","unstructured":"Hughes M, Chinoy H. Successful use of tocilizumab in a patient with psoriatic arthritis. Rheumatology (Oxford). 2013;52:1728\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"159_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jbspin.2011.06.011","volume":"79","author":"A Ogata","year":"2012","unstructured":"Ogata A, Umegaki N, Katayama I, Kumanogoh A, Tanaka T. Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab. Jt Bone Spine. 2012;79:85\u20137.","journal-title":"Jt Bone Spine"},{"key":"159_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13075-017-1249-5","volume":"19","author":"SP Raychaudhuri","year":"2017","unstructured":"Raychaudhuri SP, Raychaudhuri SK. Mechanistic rationales for targeting interleukin-17A in spondyloarthritis. Arthritis Res Ther. 2017;19:51.","journal-title":"Arthritis Res Ther"},{"key":"159_CR50","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/art.38376","volume":"66","author":"B Menon","year":"2014","unstructured":"Menon B, Gullick NJ, Walter GJ, et al. Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol. 2014;66:1272\u201381.","journal-title":"Arthritis Rheumatol"},{"key":"159_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1559-0275-11-27","volume":"11","author":"D Cretu","year":"2014","unstructured":"Cretu D, Prassas I, Saraon P, et al. Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry. Clin Proteomics. 2014;11:27.","journal-title":"Clin Proteomics"},{"key":"159_CR52","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1756-185X.2010.01540.x","volume":"13","author":"F Cantini","year":"2010","unstructured":"Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M, Cassar\u00e0 E. Psoriatic arthritis: a systematic review. Int J Rheum Dis. 2010;13:300\u201317.","journal-title":"Int J Rheum Dis"},{"key":"159_CR53","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/ard.2004.020719","volume":"63","author":"P Mease","year":"2004","unstructured":"Mease P. TNF\u03b1 therapy in psoriatic arthritis and psoriasis. Ann Rheum Dis. 2004;63:755\u20138.","journal-title":"Ann Rheum Dis"},{"key":"159_CR54","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1586\/1744666X.2016.1147954","volume":"12","author":"E Generali","year":"2016","unstructured":"Generali E, Scir\u00e8 CA, Favalli EG, Selmi C. Biomarkers in psoriatic arthritis: a systematic literature review. Expert Rev Clin Immunol. 2016;12:651\u201360.","journal-title":"Expert Rev Clin Immunol"},{"key":"159_CR55","doi-asserted-by":"publisher","unstructured":"Chiu YG, Ritchlin CT. Characterization of DC-STAMP+ cells in human bone marrow. J Bone Marrow Res. 2013;1. https:\/\/doi.org\/10.4172\/2329-8820.1000127.","DOI":"10.4172\/2329-8820.1000127"},{"key":"159_CR56","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3899\/jrheum.090167","volume":"37","author":"D Grcevic","year":"2010","unstructured":"Grcevic D, Jajic Z, Kovacic N, et al. Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness. J Rheumatol. 2010;37:246\u201356.","journal-title":"J Rheumatol"},{"key":"159_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3899\/jrheum.140223","volume":"42","author":"DR Jadon","year":"2015","unstructured":"Jadon DR, Nightingale AL, McHugh NJ, Lindsay MA, Korendowych E, Sengupta R. Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. J Rheumatol. 2015;42:21\u201330.","journal-title":"J Rheumatol"},{"key":"159_CR58","doi-asserted-by":"publisher","first-page":"R164","DOI":"10.1186\/ar3123","volume":"12","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth N, Pool B, Smith T, et al. Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther. 2010;12:R164.","journal-title":"Arthritis Res Ther"},{"key":"159_CR59","first-page":"S26","volume":"32","author":"L Riente","year":"2014","unstructured":"Riente L, Carli L, Delle Sedie A. Ultrasound imaging in psoriatic arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2014;32:S26\u201333.","journal-title":"Clin Exp Rheumatol"},{"key":"159_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/RMR.0b013e31825c008d","volume":"22","author":"MC Forney","year":"2011","unstructured":"Forney MC, Winalski CS, Schils JP. Magnetic resonance imaging of inflammatory arthropathies of peripheral joints. Top Magn Reson Imaging. 2011;22:45\u201359.","journal-title":"Top Magn Reson Imaging"},{"key":"159_CR61","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00296-016-3562-8","volume":"36","author":"FM Perrotta","year":"2016","unstructured":"Perrotta FM, Astorri D, Zappia M, Reginelli A, Brunese L, Lubrano E. An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment. Rheumatol Int. 2016;36:1579\u201383.","journal-title":"Rheumatol Int"},{"key":"159_CR62","doi-asserted-by":"publisher","first-page":"e20279","DOI":"10.1371\/journal.pone.0020279","volume":"6","author":"KM Wittkowski","year":"2011","unstructured":"Wittkowski KM, Leonardi C, Gottlieb A, et al. Clinical symptoms of skin, nails, and joints manifest independently in patients with concomitant psoriasis and psoriatic arthritis. PLoS One. 2011;6:e20279.","journal-title":"PLoS One"},{"key":"159_CR63","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2340\/00015555-1833","volume":"94","author":"K de Vlam","year":"2014","unstructured":"de Vlam K, Gottlieb AB, Mease PJ. Current concepts in psoriatic arthritis: pathogenesis and management. Acta Derm Venereol. 2014;94:627\u201334.","journal-title":"Acta Derm Venereol"},{"key":"159_CR64","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/annrheumdis-2014-206347","volume":"75","author":"D Simon","year":"2016","unstructured":"Simon D, Faustini F, Kleyer A, et al. Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis. Ann Rheum Dis. 2016;75:660\u20136.","journal-title":"Ann Rheum Dis"},{"key":"159_CR65","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/1346-8138.13212","volume":"43","author":"T Takata","year":"2016","unstructured":"Takata T, Takahashi A, Taniguchi Y, Terada Y, Sano S. Detection of asymptomatic enthesitis in psoriasis patients: an onset of psoriatic arthritis? J Dermatol. 2016;43:650\u20134.","journal-title":"J Dermatol"},{"key":"159_CR66","first-page":"1106","volume":"24","author":"C Salvarani","year":"1997","unstructured":"Salvarani C, Cantini F, Olivieri I, et al. Isolated peripheral enthesitis and\/or dactylitis: a subset of psoriatic arthritis. J Rheumatol. 1997;24:1106\u201310.","journal-title":"J Rheumatol"},{"key":"159_CR67","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40744-017-0066-2","volume":"4","author":"M Garrido-Cumbrera","year":"2017","unstructured":"Garrido-Cumbrera M, Hillmann O, Mahapatra R, et al. Improving the management of psoriatic arthritis and axial spondyloarthritis: roundtable discussions with healthcare professionals and patients. Rheumatol Ther. 2017;4:219\u201331.","journal-title":"Rheumatol Ther"},{"key":"159_CR68","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/annrheumdis-2012-202608","volume":"72","author":"W Tillett","year":"2013","unstructured":"Tillett W, Jadon D, Shaddick G, et al. Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis. 2013;72:1358\u201361.","journal-title":"Ann Rheum Dis"},{"key":"159_CR69","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1136\/ard.2011.150938","volume":"70","author":"DD Gladman","year":"2011","unstructured":"Gladman DD, Thavaneswaran A, Chandran V, Cook RJ. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis. 2011;70:2152\u20134.","journal-title":"Ann Rheum Dis"},{"key":"159_CR70","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","volume":"75","author":"L Gossec","year":"2016","unstructured":"Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75:499\u2013510.","journal-title":"Ann Rheum Dis"},{"key":"159_CR71","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/S0140-6736(15)00347-5","volume":"386","author":"LC Coates","year":"2015","unstructured":"Coates LC, Moverley AR, McParland L, et al. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet. 2015;386:2489\u201398.","journal-title":"Lancet"},{"key":"159_CR72","first-page":"11","volume":"33","author":"B Kirkham","year":"2015","unstructured":"Kirkham B, de Vlam K, Li W, et al. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial. Clin Exp Rheumatol. 2015;33:11\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"159_CR73","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/1744666X.2017.1241710","volume":"13","author":"WS Tan","year":"2017","unstructured":"Tan WS, Kelly S, Pitzalis C. Targeted therapies: what they teach us about the pathogenesis of psoriasis and psoriatic arthritis. Expert Rev Clin Immunol. 2017;13:207\u201322.","journal-title":"Expert Rev Clin Immunol"},{"key":"159_CR74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrrheum.2017.80","volume":"13","author":"S Eyre","year":"2017","unstructured":"Eyre S, Orozco G, Worthington J. The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping. Nat Rev Rheumatol. 2017;13:421\u201332.","journal-title":"Nat Rev Rheumatol"},{"key":"159_CR75","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3899\/jrheum.150642","volume":"93","author":"O Addimanda","year":"2015","unstructured":"Addimanda O, Possemato N, Caruso A, Pipitone N, Salvarani C. The role of tumor necrosis factor-\u03b1 blockers in psoriatic disease. Therapeutic options in psoriatic arthritis. J Rheumatol Suppl. 2015;93:73\u20138.","journal-title":"J Rheumatol Suppl"},{"key":"159_CR76","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/rheumatology\/ken059","volume":"47","author":"F Cantini","year":"2008","unstructured":"Cantini F, Niccoli L, Nannini C, et al. Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs. Rheumatology (Oxford). 2008;47:872\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"159_CR77","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","volume":"386","author":"IB McInnes","year":"2015","unstructured":"McInnes IB, Mease PJ, Kirkham B, et al. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015;386:1137\u201346.","journal-title":"Lancet"},{"key":"159_CR78","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","volume":"73","author":"C Ritchlin","year":"2014","unstructured":"Ritchlin C, Rahman P, Kavanaugh A, et al. Efficacy and safety of the anti-IL-12\/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial. Ann Rheum Dis. 2014;73:990\u20139.","journal-title":"Ann Rheum Dis."},{"key":"159_CR79","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/S0140-6736(17)31429-0","volume":"389","author":"P Nash","year":"2017","unstructured":"Nash P, Kirkham B, Okada M, et al. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial. Lancet. 2017;389:2317\u201327.","journal-title":"Lancet"},{"key":"159_CR80","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s13075-014-0426-z","volume":"16","author":"LG van Baarsen","year":"2014","unstructured":"van Baarsen LG, Lebre MC, van der Coelen D, et al. Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy? Arthritis Res Ther. 2014;16:426.","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 11","key":"159_CR81","first-page":"S64","volume":"63","author":"PJ Mease","year":"2011","unstructured":"Mease PJ. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander\/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S64\u201385.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"159_CR82","doi-asserted-by":"publisher","first-page":"e000415","DOI":"10.1136\/rmdopen-2016-000415","volume":"3","author":"PJ Mease","year":"2017","unstructured":"Mease PJ, Kavanaugh A, Coates LC, et al. Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial. RMD Open. 2017;3:e000415.","journal-title":"RMD Open"},{"key":"159_CR83","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/annrheumdis-2012-201341","volume":"72","author":"PS Helliwell","year":"2013","unstructured":"Helliwell PS, FitzGerald O, Fransen J, et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis. 2013;72:986\u201391.","journal-title":"Ann Rheum Dis"},{"key":"159_CR84","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.semarthrit.2017.10.021","volume":"47","author":"PJ Mease","year":"2018","unstructured":"Mease PJ, Coates LC. Considerations for the definition of remission criteria in psoriatic arthritis. Semin Arthritis Rheum. 2018;47:786\u201396.","journal-title":"Semin Arthritis Rheum"},{"key":"159_CR85","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/acr.22529","volume":"67","author":"A Haddad","year":"2015","unstructured":"Haddad A, Thavaneswaran A, Ruiz-Arruza I, et al. Minimal disease activity and anti-tumor necrosis factor therapy in psoriatic arthritis. Arthritis Care Res (Hoboken). 2015;67:842\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"159_CR86","first-page":"1151","volume":"68","author":"A Mies Richie","year":"2003","unstructured":"Mies Richie A, Francis ML. Diagnostic approach to polyarticular joint pain. Am Fam Physician. 2003;68:1151\u201360.","journal-title":"Am Fam Physician"},{"key":"159_CR87","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/annrheumdis-2016-eular.4120","volume":"75","author":"E Maman","year":"2016","unstructured":"Maman E, Masson-Behar V, Coustet B, Palazzo E, Dieude P, Ottaviani S. Enthesitis in rheumatoid arthritis and spondyloarthritis: an ultrasound study. Ann Rheum Dis. 2016;75:1226.","journal-title":"Ann Rheum Dis"},{"key":"159_CR88","volume-title":"Ankylosing spondylitis","author":"K Wenker","year":"2018","unstructured":"Wenker K, Quint JM. Ankylosing spondylitis. Treasure Island: StatPearls; 2018."},{"key":"159_CR89","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/ard.62.1.68","volume":"62","author":"R Queiro-Silva","year":"2003","unstructured":"Queiro-Silva R, Torre-Alonso JC, Tintur\u00e9-Eguren T, L\u00f3pez-Lagunas I. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis. 2003;62:68\u201370.","journal-title":"Ann Rheum Dis"},{"key":"159_CR90","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/ard.42.2.117","volume":"42","author":"DA Raddatz","year":"1983","unstructured":"Raddatz DA, Mahowald ML, Bilka PJ. Acute polyarticular gout. Ann Rheum Dis. 1983;42:117\u201322.","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-019-0159-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-019-0159-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-019-0159-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T12:50:51Z","timestamp":1714654251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-019-0159-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9,1]]}},"alternative-id":["159"],"URL":"https:\/\/doi.org\/10.1007\/s40744-019-0159-1","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}